Suppr超能文献

肾功能变化与急性脑卒中后再发卒中及痴呆的风险:来自培哚普利预防复发性卒中研究的结果。

Risk of recurrent stroke and dementia following acute stroke by changes in kidney function: results from the Perindopril Protection Against Recurrent Stroke Study.

机构信息

The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

出版信息

J Hypertens. 2024 Aug 1;42(8):1313-1321. doi: 10.1097/HJH.0000000000003711. Epub 2024 Mar 8.

Abstract

BACKGROUND

Limited data exist on the relationship between declining kidney function and cardiovascular events, dementia, and mortality in patients with a history of stroke.Thus the aims of the study were to investigate functional relationships between dynamic kidney function change and cardiovascular outcomes, and clarify whether adding kidney parameters to conventional cardiovascular risk factors improves model discrimination.

METHODS

Post hoc analysis of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) clinical trial of blood pressure lowering for the secondary prevention of stroke. We examined the association between dynamic kidney function defined as percentage change (declines of >30%, and >0 to ≤30%, and increases of ≥0 to <30%, and ≥30%) in estimated glomerular filtration rate (eGFR) over 2 years and recurrent stroke, major cardiovascular events, dementia and all-cause death over the next 2 years using Cox proportional hazard models controlling for eGFR at registration and potential confounders. Restricted cubic splines were used to assess the functional relationships. C-statistics and Net Reclassification Improvement (NRI) at 2 years were used to assess model discrimination.

RESULTS

In 4591 patients followed for a mean of approximately 2 years, 254 (5.5%) developed recurrent stroke, 391 (8.5%) had a major cardiovascular event, 221 (4.8%) developed dementia, and 271 (5.9%) died. Reverse J-like or U-like relationships were observed for percent declines in eGFR and outcomes. Using declines in eGFR of >0 to ≤30% as a reference, increased risks were evident for a greater decline (>30%) in relation to recurrent stroke [adjusted hazard ratio 1.85, 95% confidence interval (CI) 1.20-2.85], major cardiovascular event (2.24, 1.62-3.10) and all-cause death (2.09, 1.39-3.15). A larger increase (≥30%) in eGFR was also associated with a greater risk of all-cause death (1.96, 1.14-3.37). Improvements in the C-statistic were found by adding baseline eGFR and percent change compared with a model with conventional cardiovascular risk factors alone, for major cardiovascular events, dementia, and all-cause mortality.

CONCLUSION

Declining kidney function following an incident cerebrovascular event is associated with additional risk of a major cardiovascular events, dementia, and 2-year mortality. However, a large increase in kidney function was also found to be associated with a higher risk of mortality.

摘要

背景

在有中风病史的患者中,关于肾功能下降与心血管事件、痴呆和死亡率之间的关系,目前的数据有限。因此,本研究的目的是探讨动态肾功能变化与心血管结局之间的功能关系,并阐明在常规心血管危险因素之外增加肾脏参数是否能提高模型的判别能力。

方法

对降压治疗二级预防中风的培哚普利预防复发性卒中研究(PROGRESS)临床试验进行事后分析。我们使用 Cox 比例风险模型,根据 2 年内估算肾小球滤过率(eGFR)的百分比变化(下降 >30%、>0 至 ≤30%、增加≥0 至 <30%和≥30%),研究动态肾功能与 2 年内复发性卒中、主要心血管事件、痴呆和全因死亡之间的相关性,该模型控制了登记时的 eGFR 和潜在混杂因素。限制性三次样条用于评估功能关系。C 统计量和 2 年内净重新分类改善(NRI)用于评估模型判别能力。

结果

在 4591 名平均随访约 2 年的患者中,254 名(5.5%)发生复发性卒中,391 名(8.5%)发生主要心血管事件,221 名(4.8%)发生痴呆,271 名(5.9%)死亡。eGFR 百分比下降与结局之间观察到反向 J 形或 U 形关系。以 eGFR 下降 0 至 ≤30%为参照,eGFR 下降>30%与复发性卒中[校正后的危险比 1.85,95%置信区间(CI)1.20-2.85]、主要心血管事件(2.24,1.62-3.10)和全因死亡(2.09,1.39-3.15)相关的风险增加。eGFR 的较大增加(≥30%)也与全因死亡风险增加相关(1.96,1.14-3.37)。与仅使用常规心血管危险因素的模型相比,在基线 eGFR 和百分比变化的基础上添加这些参数,可提高主要心血管事件、痴呆和全因死亡率的 C 统计量。

结论

脑血管事件后肾功能下降与主要心血管事件、痴呆和 2 年死亡率的风险增加有关。然而,我们还发现,肾功能的大幅增加也与更高的死亡率相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验